Evidence map›Paper›PMID 34769265›Full record

ArticleInternational journal of molecular sciences2021

Distinct Exosomal miRNA Profiles from BALF and Lung Tissue of COPD and IPF Patients.

Gagandeep Kaur, Krishna Prahlad Maremanda, Michael Campos, Hitendra S Chand, Feng Li, Nikhil Hirani, M A Haseeb, Dongmei Li, Irfan Rahman

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. The dual promise of extracellular vesicles in lung diseases: towards reliable biomarkers and drug delivery vectors.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Gagandeep KaurDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Krishna Prahlad MaremandaDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Michael CamposDivision of Pulmonary, Allergy, Critical Care, University of Miami School of Medicine, Miami, FL 33136, USA.
Hitendra S ChandDepartment of Immunology and Nanomedicine, Florida International University, Miami, FL 33199, USA.ORCID 0000-0002-0574-9307
Feng LiCentre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Nikhil HiraniCentre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
M A HaseebDepartment of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA.
Dongmei LiClinical and Translational Science Institute (CTSI), Public Health Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-9140-2483
Irfan RahmanDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-2274-2454
University of Rochester Medical Center · USQueen's Medical Centre · GBFlorida International University · USSUNY Downstate Health Sciences University · USUniversity of Miami · US

Funding

Novel long noncoding RNAs in the airway mucous responseR21AI144374 · NIAID · FLORIDA INTERNATIONAL UNIVERSITY · PI LAKSHMANA, MADEPALLI KRISHNAPPA · 2019 to 2020
$625k
LncRNA in Alzheimer's Disease-Associated Neuroinflammation and NeurodegenerationR21AI152937 · NIAID · FLORIDA INTERNATIONAL UNIVERSITY · PI LAKSHMANA, MADEPALLI KRISHNAPPA · 2020 to 2021
$597k
NIAID NIH HHS R21 AI144374NIAID NIH HHS R21 AI152937NIH Office of the Director HL137738, HL133404 and HL135613
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are chronic, progressive lung ailments that are characterized by distinct pathologies. Early detection biomarkers and disease mechanisms for these debilitating diseases are lacking. Extracellular vesicles (EVs), including exosomes, are small, lipid-bound vesicles attributed to carry proteins, lipids, and RNA molecules to facilitate cell-to-cell communication under normal and diseased conditions. Exosomal miRNAs have been studied in relation to many diseases. However, there is little to no knowledge regarding the miRNA population of bronchoalveolar lavage fluid (BALF) or the lung-tissue-derived exosomes in COPD and IPF. Here, we determined and compared the miRNA profiles of BALF- and lung-tissue-derived exosomes of healthy non-smokers, smokers, and patients with COPD or IPF in independent cohorts. Results: Exosome characterization using NanoSight particle tracking and TEM demonstrated that the BALF-derived exosomes were ~89.85 nm in size with a yield of ~2.95 × 10

Indexed as

ExosomesIdiopathic Pulmonary FibrosisMicroRNAsPulmonary Disease, Chronic ObstructiveTranscriptomeAdultAgedAged, 80 and overBronchoalveolar Lavage FluidFemaleHumansMaleMiddle AgedMicroRNAsBALFbiomarkerCOPDexosomeslungsmiRNA

Identifiers

PMID34769265
PMCPMC8584050
OpenAlexW3210194031

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.